Clinical efficacy of Daikenchuto (DKT: TJ-100) for gastrointestinal dysfunction following open total gastrectomy (a randomized, double-blind, multi-center, placebo-controlled study)

Trial Profile

Clinical efficacy of Daikenchuto (DKT: TJ-100) for gastrointestinal dysfunction following open total gastrectomy (a randomized, double-blind, multi-center, placebo-controlled study)

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Mar 2017

At a glance

  • Drugs TJ 100 (Primary)
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Mar 2017 New trial record
    • 24 Feb 2017 A pooled analysis of three randomized controlled trials (UMIN000001592, UMIN000003103 and UMIN000004693) is being conducted and is registered in UMIN (UMIN000026292, Daikenchuto for enhancement of bowel movement after open abdominal surgery: a pooled analysis of three randomized controlled trials) with primary endpoint 'the time from the first meal after extubation to the first evacuation'.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top